OMSTA 20MG CAP

INDICATIONS:

• Omsta (omeprazole) capsules is indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks of therapy.
• Omsta (omeprazole) capsule is indicated in Helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence.
• Omsta (omeprazole) is indicated for short term treatment (4 to 8 weeks) of active benign gastric ulcer in adults.
• Omsta (omeprazole) is indicated for the treatment of heartburn and other symptoms associated with GERD for up to 4 weeks in patients 1 year of age and older.
• Omsta (omeprazole) is indicated in pediatric patients 1 year of age to adults for short term treatment (4 to 8 weeks) of Erosive Esophagitis (EE) due to acid mediated GERD that has been diagnosed by endoscopy in patients 1 year of age and older.
• Omsta (omeprazole) is indicated in pediatric patients 1 month to less than 1 year of age for short term treatment (up to 6 weeks) of EE due to acid mediated GERD.
• Omsta is indicated for the long term treatment of pathological hypersecretory conditions (e.g Zollinger-Ellison syndrome, multiple endocrine adenomas and systemic mastocytosis) in adults.